Select Country

Select a country to view information on local trademark law


Countries
A-E  F-J  K-O  P-T  U-Z

Multinational Agreements
EUIPO  WIPO
AIPO/OAPI  ARIPO
Enter Client Voucher:  info

Get Listed

Promote your expertise to IP professionals worldwide.
read more

Subscribe to Free Newsletter

To keep updated on the latest amendments to international trademark laws click here

Amendments to Trademark Laws

Print this page
Jun 11, 2020 (Newsletter Issue 9/20)
Russian Federation
Show Country Survey

Drug Labeling Introduced


From July 1, 2020, all pharmaceutical products for medical use in Russia will have to be labelled in accordance with the federal information system for monitoring the circulation of pharmaceutical products. In order to meet the requirements, each pharmaceutical product will have a unique identifier on its packaging, a Data Matrix code, containing information such as the product’s serial number, expiration date, consignment number and manufacturer’s name, thus enabling the monitoring of each product’s circulation from the manufacturer to the end user.

The drug monitoring system was introduced by the Federal Law No. 425-FZ of December 28, 2017, which brought changes to the Federal Law ‘On Circulation of Medicines’. It was first intended to enter into force on January 1, 2020, but the entry into force was postponed until July 1, 2020 by further amendments to the Federal Law ‘On Circulation of Medicines’ introduced on December 27, 2019.

For more information, please click here

Source: www.petosevic.com